Skip to main content
. 2023 Jan 19;14:999449. doi: 10.3389/fmicb.2023.999449

Table 2.

The MIC and MBC results of Disaspidin BB on Staphylococcus epidermidis.

Strains Drugs(μg/mL)
Disaspidin BB Erythromycin
MIC MBC MIC MBC
SEP-01 1.67 ± 0.59** 9.17 ± 7.73 0.26 ± 0.07 1.67 ± 0.59
SEP-02 0.63 ± 0.00** 1.04 ± 0.29 0.13 ± 0.04 0.73 ± 0.39
SEP-03 1.04 ± 0.29** 4.58 ± 3.86 73.33 ± 14.90 120.00 ± 40.00
SEP-04 2.50 ± 0.00** 26.67 ± 9.43 120.00 ± 40.00 906.67 ± 527.97
SEP-05 0.63 ± 0.00** 20.00 ± 0.00 160.00 ± 0.00 373.33 ± 199.56
SEP-06 1.04 ± 0.29** 26.67 ± 9.43 160.00 ± 0.00 533.33 ± 150.85
SEP-07 1.25 ± 0.00** 5.00 ± 0.00 133.33 ± 37.71 >2560.00
SEP-08 0.63 ± 0.00** 1.67 ± 0.59 53.33 ± 18.86 106.67 ± 37.71
SEP-09 0.73 ± 0.23** 1.25 ± 0.00 0.16 ± 0.00 3.75 ± 1.25
SEP-10 0.63 ± 0.00** 3.75 ± 1.77 0.31 ± 0.00 1.46 ± 0.78
SEP-11 0.73 ± 0.23** 0.94 ± 0.31 10.00 ± 0.00 33.33 ± 9.43

SEP-01 ~ 11 means clinical strains of S. epidermidis 01 ~ 11; **means p < 0.01.